# US 2008/0286790 A1 · Method for Diagnosing Overactive Bladder

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0286790 A1
- Document ID: US20080286790A1
- Status: Published application
- Kind: A1
- Application number: 12/116,307
- Filed: 2008-05-07
- Published: 2008-11-20
- Earliest claimed: 2007-05-16
- Assignees: Wellman Wai-Man Cheung; Martin Heath Bluth
- Inventors: Martin Heath Bluth; Wellman W. Cheung
- Web page: https://patentgrep.com/patent/US20080286790A1

## CPC

- G01N 33/6893: {related to diseases not provided for elsewhere}
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/158: Expression markers
- G01N 2800/341: Urinary incontinence
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Techniques for diagnosing overactive bladder (OAB) in a patient are provided. For example, a technique for diagnosing overactive bladder in a patient includes the step of obtaining peripheral blood mononuclear cells (PBMC) from the patient to provide a reporter function in the patient.

## Claims

### Claim 1

A method of diagnosing overactive bladder (OAB) in a patient, the method comprising the step of obtaining peripheral blood mononuclear cells (PBMC) from the patient to provide a reporter function in the patient.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of obtaining PBMC from the patient comprises the steps of:
obtaining whole blood from the patient in an amount in a range of about four to six milliliters (ml); and
isolating PBMC from the whole blood by density centrifugation.

### Claim 3 (depends on 1)

The method of claim 1, wherein providing a reporter function in the patient comprises processing the PBMC to isolate RNA for analysis, wherein the analysis comprises comparing gene changes in the patient versus gene changes in a control sample to provide a screening modality to ascertain at least one gene involved in a pathogenesis of overactive bladder.

### Claim 4 (depends on 3)

The method of claim 3, wherein the at least one gene involved in the pathogenesis of overactive bladder comprises at least one of progesterone receptor membrane component 1 (PGRMC1), eukaryotic initiation factor (EIF2S3), complement receptor (C3AR1), myomesin M-protein (MYOM2), platelet-derived growth factor (PDGF), microfibrillar-associated protein (MFAP3L), and tropomyosin (TPM1).
